Wants to be innovative, can't figure out how. Under large amount of change - GOT THE PACKAGE - werkgeversreview Associate Director bij Merck

2,0
24 apr 2014
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

good pay, very flexible working arrangements. Remote work I enjoyed working from home. All of my contacts were in other sites and because Merck didn't want to pay for travel they wanted everything to be done via WebEx. I got moved from an office to a cubical the size of a phone booth. I gave up my office because no one I worked with was there, contractors were offsite as well as the customers (Asia, Europe, and other Merck Sites). Loved that part of the job.

Minpunten

very process heavy. Company trying to streamline but still clings to heavy process and approvals from multiple levels. No raises beyond cost of living. No in-place promotions. New positions are "hidden" and candidates are favored. I was laid off in an effort to consolidate jobs. I'm not bitter, but as a company, Merck is confused and trying really hard to be all the buzz words; lean, efficient, innovative, blah, blah blah. The goals are so vague and full of CIO speak it's hard to see the real reason you should be doing something. They talk the game but know nothing. Management is too busy covering their own butts.

Ontdek andere reviews over Merck

5,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent company to work with.

Minpunten

No cons encountered so far

4,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Minpunten

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle